- Home
- NBY vs BGB Comparison
NBY vs BGB Comparison
Compare NBY & BGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- BGB
- Stock Information
- Founded
- NBY 2000
- BGB 2012
- Country
- NBY United States
- BGB United States
- Employees
- NBY N/A
- BGB N/A
- Industry
- NBY
- BGB Trusts Except Educational Religious and Charitable
- Sector
- NBY
- BGB Finance
- Exchange
- NBY Nasdaq
- BGB Nasdaq
- Market Cap
- NBY 3.5M
- BGB N/A
- IPO Year
- NBY 2007
- BGB N/A
- Fundamental
- Price
- NBY $0.61
- BGB $12.40
- Analyst Decision
- NBY
- BGB
- Analyst Count
- NBY 0
- BGB 0
- Target Price
- NBY N/A
- BGB N/A
- AVG Volume (30 Days)
- NBY 7.7M
- BGB 154.6K
- Earning Date
- NBY 11-07-2024
- BGB 01-01-0001
- Dividend Yield
- NBY N/A
- BGB 9.75%
- EPS Growth
- NBY N/A
- BGB N/A
- EPS
- NBY N/A
- BGB N/A
- Revenue
- NBY $13,884,000.00
- BGB N/A
- Revenue This Year
- NBY N/A
- BGB N/A
- Revenue Next Year
- NBY $26.04
- BGB N/A
- P/E Ratio
- NBY N/A
- BGB N/A
- Revenue Growth
- NBY 4.06
- BGB N/A
- 52 Week Low
- NBY $0.36
- BGB $10.40
- 52 Week High
- NBY $14.35
- BGB $11.97
- Technical
- Relative Strength Index (RSI)
- NBY 44.54
- BGB 59.41
- Support Level
- NBY $0.60
- BGB $12.20
- Resistance Level
- NBY $0.70
- BGB $12.50
- Average True Range (ATR)
- NBY 0.04
- BGB 0.09
- MACD
- NBY -0.01
- BGB 0.00
- Stochastic Oscillator
- NBY 10.00
- BGB 80.78
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.